First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine.
First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine.
复制标题
靶向种系的首次临床研究:接近成功的基于BNAB的HIV疫苗的一步。
DOI:
10.1016/j.xinn.2023.100374
复制
发表时间:
2023-01-30
期刊:
影响因子:
32.1
通讯作者:
Wen, Ziyu
中科院分区:
文献类型:
--
作者:
Sun, Caijun;Zuo, Teng;Wen, Ziyu
The epidemic of human immunodeficiency virus type 1 (HIV-1) remains a major threat to global public health, with approximately 38 million people living with HIV-1 worldwide. However, a prophylactic vaccine against HIV-1 is not available yet. In a recent study, 1 Leggat and colleagues reported the first-in-human test of a germline-targeting HIV-1 vaccine candidate, eOD–GT8 60-mer adjuvanted withAS01B. Encouragingly, this strategy effectively activated the B cell precursors (germlines) of VRC01-class broadly neutralizing antibodies (bnAbs) in 97%(35 of 36) of vaccine recipients. Moreover, these activated precursors shared properties with mature bnAbs and acquired substantial somatic hypermutation (SHM) and affinity maturation. This study not only establishes the clinical proof
登录
查看更多内容
DOI:
10.1038/s41577-022-00753-w
发表时间:
2023-03
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1126/science.1234150
发表时间:
2013-05-10
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Jardine J;Julien JP;Menis S;Ota T;Kalyuzhniy O;McGuire A;Sok D;Huang PS;MacPherson S;Jones M;Nieusma T;Mathison J;Baker D;Ward AB;Burton DR;Stamatatos L;Nemazee D;Wilson IA;Schief WR
通讯作者:
Schief WR
DOI:
10.1126/science.aad9195
发表时间:
2016-03-25
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Jardine JG;Kulp DW;Havenar-Daughton C;Sarkar A;Briney B;Sok D;Sesterhenn F;Ereño-Orbea J;Kalyuzhniy O;Deresa I;Hu X;Spencer S;Jones M;Georgeson E;Adachi Y;Kubitz M;deCamp AC;Julien JP;Wilson IA;Burton DR;Crotty S;Schief WR
通讯作者:
Schief WR
影响因子:
8.7
作者:
Verkoczy L;Alt FW;Tian M
通讯作者:
Tian M
影响因子:
56.9
作者:
Leggat, David J.;Cohen, Kristen W.;Schief, William R.
通讯作者:
Schief, William R.